Present Scenario and Growth Prospects of Hydroxychloroquine (Plaquenil) Market Over The Period 2020-2025 | Sanofi, Actavis (TEVA), Mylan, Novartis, Covis Pharma, Apotex, Sun Pharma, Zydus Cadila

Global Hydroxychloroquine (Plaquenil) Market Synopsis:

The exclusive research report on the Global Hydroxychloroquine (Plaquenil) Market 2020-2025 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market. Global Hydroxychloroquine (Plaquenil) Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe.

According to the market research study, the Hydroxychloroquine (Plaquenil) is racemic mixture consisting of an R and S enantiomer. Hydroxychloroquine (Plaquenil) is an aminoquinoline like chloroquine. Hydroxychloroquine (Plaquenil) is commonly prescribed medication in the treatment of uncomplicated malaria, rheumatoid arthritis, chronic discoid lupus erythematosus, and systemic lupus erythematosus. Hydroxychloroquine (Plaquenil) is also used for the prophylaxis of malaria in regions where chloroquine resistance is unlikely. It was developed during World War II as a derivative of quinacrine with less severe side effects. Chloroquine and hydroxychloroquine are both being investigated for the treatment of SARS-CoV-2. It is taken by mouth. Hydroxychloroquine (Plaquenil) is also being used as an experimental treatment for coronavirus disease 2019 (COVID-19).

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/258560 .

Significant points in table of contents: Market Definition, Market Overview, Business Introduction, Segmentation (Region Level), Segmentation (Type Level), Segmentation (Industry Level), Segmentation (Channel Level), Market Forecast Year, Segmentation Type, Segmentation Industry, Market Cost Analysis, and Conclusion. The Hydroxychloroquine (Plaquenil) Market is segmented based on Product, source, application and Regions. On the basis of product, the market is sub-segmented.

Regionally, North America and Europe holds major share in Global Hydroxychloroquine (Plaquenil) Market. Moreover, Asia-Pacific is expected to record higher growth rate in Hydroxychloroquine (Plaquenil) market during the forecast year.

Top Major Key Players in the Global Hydroxychloroquine (Plaquenil) Market:

1 Sanofi

2 Actavis (TEVA )

3 Mylan

4 Novartis

5 Covis Pharmaceutical

6 Cardinal Health

7 Apotex Corporation

8 Hikma Pharmaceuticals

9 Aphena Pharma

10 Concordia Healthcare

11 AvKARE (Amneal Pharmaceuticals)

12 Ipca Laboratories

13 Shanghai Pharmaceuticals Holding

14 Taj Pharmaceuticals

15 Cinkate Corporation

16 Cadila Healthcare

17 Sun Pharma

18 Zydus Cadila

19 Advanz Pharma

20 Bristol Laboratories

21 Hanlim Pharmaceutical

22 Kyung Poong and More……………….

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Hydroxychloroquine (Plaquenil) Market Report 2020” @ https://www.businessindustryreports.com/buy-now/258560/single .

Product Type Segmentation

1 100mg

2 200mg

3 Others

Industry Segmentation

1 Lupus Erythematosus

2 Rheumatoid Arthritis

3 COVID-19

4 Others

Big Medical Industry News:

Novartis (October 05, 2020) - New Phase III analysis demonstrates Novartis Beovu showed improvement in best-corrected visual acuity in wet AMD patients with early persistent fluid - Novartis today announced that results of two new post-hoc analyses of the Phase III HAWK and HARRIER clinical trials in wet age-related macular degeneration (AMD) were presented at the EURETINA 2020 virtual congress. The first analysis demonstrated fewer Beovu (brolucizumab) patients had early persistent fluid, defined as the presence of intra-retinal fluid and/or sub-retinal fluid through week 12 of treatment, compared with aflibercept patients. For patients who did have early persistent fluid, those treated with Beovu achieved greater best-corrected visual acuity (BCVA) gains and greater reductions in central subfield thickness (CST) at week 96 versus those treated with aflibercept.

A second analysis showed Beovu was associated with better control of retinal fluid, as measured by achievement and maintenance of defined CST levels. In the study, more Beovu patients than aflibercept patients achieved CST control (80% vs. 69% at week 96 at a defined CST threshold of 320 µm, respectively). Patients who stayed longer in a controlled CST state had better visual gains compared with those who remained in an uncontrolled CST state. CST is a key indicator of fluid in the retina, and drying the retina is a core aim of treatment for wet AMD.

“The data presented at EURETINA suggests Beovu can better help patients who have persistent retinal fluid achieve disease control by reducing CST and improving their vision in the long term,” said Dirk Sauer, Global Head Development, Novartis Pharma Ophthalmology. “These results further strengthen our confidence in Beovu as an effective and important treatment option for wet AMD patients aiming to improve their vision.”

Novartis has nine podium presentations at the congress and is sponsoring a Beovu symposium and an independent medical education program conducted by EURETINA.

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/258560 .

Major Points in Table of Contents:

Global Hydroxychloroquine (Plaquenil) Market Report 2020

1 Hydroxychloroquine (Plaquenil) Product Definition

2 Global Hydroxychloroquine (Plaquenil) Market Manufacturer Share and Market Overview

3 Manufacturer Hydroxychloroquine (Plaquenil) Business Introduction

4 Global Hydroxychloroquine (Plaquenil) Market Segmentation (Region Level)

5 Global Hydroxychloroquine (Plaquenil) Market Segmentation (Product Type Level)

6 Global Hydroxychloroquine (Plaquenil) Market Segmentation (Industry Level)

7 Global Hydroxychloroquine (Plaquenil) Market Segmentation (Channel Level)

8 Hydroxychloroquine (Plaquenil) Market Forecast 2020-2025

9 Hydroxychloroquine (Plaquenil) Segmentation Product Type

10 Hydroxychloroquine (Plaquenil) Segmentation Industry

11 Hydroxychloroquine (Plaquenil) Cost of Production Analysis

12 Conclusion

………………. Request free sample to get a complete Table of Content

About us

BusinessindustryReports.com is a digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic, and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.